Is this the end of colonoscopy screening for colorectal cancer? An Asia-Pacific perspective
J Gastroenterol Hepatol
.
2023 May;38(5):671-677.
doi: 10.1111/jgh.16182.
Epub 2023 Mar 28.
Authors
Rashid N Lui
1
2
,
Sunny H Wong
3
,
Nik Sheng Ding
4
5
,
Masau Sekiguchi
6
7
,
Jun Yu
1
2
,
Tiing-Leong Ang
8
,
Khay-Guan Yeoh
9
10
,
Han-Mo Chiu
11
12
,
Joseph J Y Sung
3
Affiliations
1
Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong SAR, China.
2
Institute of Digestive Disease, State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.
3
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
4
Department of Gastroenterology, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia.
5
Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.
6
Cancer Screening Center/Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
7
Division of Screening Technology, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
8
Changi General Hospital, SingHealth Group, Singapore, Singapore.
9
Department of Gastroenterology and Hepatology, National University Hospital, Singapore, Singapore.
10
Department of Medicine, Yong Loo Lin School of Medicine, National University Singapore, Singapore, Singapore.
11
Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
12
Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
PMID:
36987587
DOI:
10.1111/jgh.16182
No abstract available
Publication types
Editorial
Comment
MeSH terms
Asia / epidemiology
Colonoscopy
Colorectal Neoplasms* / diagnosis
Colorectal Neoplasms* / epidemiology
Colorectal Neoplasms* / prevention & control
Early Detection of Cancer*
Humans
Mass Screening
Occult Blood